MAGGIE WILDEROTTER Insider Trading $JUNO Juno Therapeutics, Inc.
Get free email notifications about insider trading for MAGGIE WILDEROTTER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MAGGIE WILDEROTTER. MAGGIE WILDEROTTER is Director in AIRBORNE INC /DE/ ($ABF) and Director in CADENCE DESIGN SYSTEMS INC ($CDN) and Chairman & CEO in FRONTIER COMMUNICATIONS CORP ($CZN) and Executive Chairman in FRONTIER COMMUNICATIONS CORP ($CZN) and Director in COSTCO WHOLESALE CORP /NEW ($COST) and Director in XEROX CORP ($XRX) and Director in DOCUSIGN, INC. ($DOCU) and Director in DreamWorks Animation SKG, Inc. ($DWA) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Hewlett Packard Enterprise Co ($HPE) and Director in Lyft, Inc. ($LYFT) and Director in Sana Biotechnology, Inc. ($SANA).
MAGGIE WILDEROTTER in Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MAGGIE WILDEROTTER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MAGGIE WILDEROTTER in Juno Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABF, CDN, COST, DOCU, DWA, CZN, HPE, JUNO, LYFT, SANA, XRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2018 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
| Mar 07 2018 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
| Mar 07 2018 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
| Mar 07 2018 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | D | 8.72 | 75,000 | 654,000 | 0 | |
| Jun 19 2017 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
| Jun 21 2016 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | A | 42.40 | 12,000 | 508,800 | 12,000 | |
| Jun 16 2015 | JUNO | Juno Therapeutics, ... | Wilderotter Mary Agnes | Director | Option Exercise | A | 60.00 | 12,000 | 720,000 | 12,000 |
Page: 1